EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.5.1.B15 | Coinfection |
27928075 |
Detecting Mutations in the Mycobacterium tuberculosis Pyrazinamidase Gene pncA to Improve Infection Control and Decrease Drug Resistance Rates in Human Immunodeficiency Virus Coinfection. |
ongoing research therapeutic application unassigned |
2 1 0 |
3.5.1.B15 | Hypersensitivity |
10986252 |
Expression of Mycobacterium smegmatis pyrazinamidase in Mycobacterium tuberculosis confers hypersensitivity to pyrazinamide and related amides. |
ongoing research unassigned |
4 0 |
3.5.1.B15 | Infections |
27928075 |
Detecting Mutations in the Mycobacterium tuberculosis Pyrazinamidase Gene pncA to Improve Infection Control and Decrease Drug Resistance Rates in Human Immunodeficiency Virus Coinfection. |
ongoing research therapeutic application unassigned |
2 1 0 |
3.5.1.B15 | Leprosy |
3546548 |
Identification of cat leprosy bacillus grown in mice. |
unassigned |
0 |
3.5.1.B15 | Paratuberculosis |
3740613 |
Biochemical characteristics of various strains of Mycobacterium paratuberculosis. |
therapeutic application unassigned |
1 0 |
3.5.1.B15 | Tuberculosis |
330364 |
Cytochemical and biological properties of Mycobacterium bovis BCG. |
diagnostic usage unassigned |
3 0 |
3.5.1.B15 | Tuberculosis |
2508544 |
Does pyrazinoic acid as an active moiety of pyrazinamide have specific activity against Mycobacterium tuberculosis? |
unassigned |
0 |
3.5.1.B15 | Tuberculosis |
3129848 |
Pyrazinamidase activity of Mycobacterium tuberculosis--a test of sensitivity to pyrazinamide. |
diagnostic usage unassigned |
2 0 |
3.5.1.B15 | Tuberculosis |
3789528 |
Pyrazinamide is not active in vitro against Mycobacterium avium complex. |
therapeutic application unassigned |
1 0 |
3.5.1.B15 | Tuberculosis |
3923467 |
[Pyrazinamidase activity and sensitivity to pyrazinamide in tuberculosis bacteria] |
ongoing research therapeutic application unassigned |
3 1 0 |